Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 27, 2016 ) Publisher's, 'Peripheral Neuropathic Pain - Pipeline Review, H1 2016', provides an overview of the Peripheral Neuropathic Pain pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Peripheral Neuropathic Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Peripheral Neuropathic Pain and features dormant and discontinued projects.
Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Peripheral Neuropathic Pain - The report reviews pipeline therapeutics for Peripheral Neuropathic Pain by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Peripheral Neuropathic Pain therapeutics and enlists all their major and minor projects - The report assesses Peripheral Neuropathic Pain therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Peripheral Neuropathic Pain
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001242070/sample
Table of Content: An Overview
Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Global Markets Direct Report Coverage 7 Peripheral Neuropathic Pain Overview 8 Therapeutics Development 9 Pipeline Products for Peripheral Neuropathic Pain - Overview 9 Pipeline Products for Peripheral Neuropathic Pain - Comparative Analysis 10 Peripheral Neuropathic Pain - Therapeutics under Development by Companies 11 Peripheral Neuropathic Pain - Therapeutics under Investigation by Universities/Institutes 12 Peripheral Neuropathic Pain - Pipeline Products Glance 13 Late Stage Products 13 Clinical Stage Products 14 Early Stage Products 15 Peripheral Neuropathic Pain - Products under Development by Companies 16 Peripheral Neuropathic Pain - Products under Investigation by Universities/Institutes 17 Peripheral Neuropathic Pain - Companies Involved in Therapeutics Development 18 Achelios Therapeutics, Inc. 18 AnaBios Corporation 19 Chromocell Corporation 20 Eli Lilly and Company 21 GW Pharmaceuticals Plc 22
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001242070/discount
Nektar Therapeutics 23 Phosphagenics Limited 24 Spherium Biomed S.L. 25 Sunovion Pharmaceuticals Inc. 26 Zynerba Pharmaceuticals, Inc. 27 Peripheral Neuropathic Pain - Therapeutics Assessment 28 Assessment by Monotherapy Products 28 Assessment by Target 29 Assessment by Mechanism of Action 31 Assessment by Route of Administration 33 Assessment by Molecule Type 35 Drug Profiles 37 AXPN-03 - Drug Profile 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 CC-8464 - Drug Profile 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 DSP-2230 - Drug Profile 39 Product Description 39 Mechanism of Action 39 R&D Progress 39 duloxetine hydrochloride DR - Drug Profile 40 Product Description 40 Mechanism of Action 40 R&D Progress 40
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001242070/buy/2000
About Us:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us: Email: sales@reportsweb.com Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|